LicianPro

DMAA stock

Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) short interest & short volume · 0.3% of float short

Drugs Made In America Acquisition Corp. Ordinary Shares official short interest (FINRA, twice monthly) and daily short volume (FINRA Reg SHO), with history, % of float and days to cover.

What changed

DMAA short interest was little changed at 89K shares in the Oct 15, 2026 report (0.3% of float, 8.3 days to cover). Daily short volume averaged 45.8% of volume over the last 20 sessions, up from 39.2% the 20 sessions before, the 97th percentile of its own 20-day averages since Sep 16, 2025.

Short interest

Official, twice monthly · settled Oct 15, 2026

Shares short
89K
prior 90K
% of float
0.3%
float 27.3M
Days to cover
8.3
avg vol 11K
Change vs prior report
-0.8%

6 reports

The last 24 reports (about a year) with Lician Pro.Start 3-day trial — $149/yr

DMAA short interest by FINRA report (last 6) · price is the close on the report date
Report dateShares short$ value shortChange% floatDays to coverPrice
Oct 15, 202689K$968K-0.8%0.3%8.3$10.87
Sep 30, 202690K$977K-3.0%0.3%101.0$10.88
Sep 15, 202693K$1.0M+16.5%0.3%1.3$10.84
Aug 31, 202679K$853K-1.5%0.3%5.0$10.75
Aug 14, 202681K$863K-9.1%0.3%155.9$10.71
Jul 31, 202689K$949K-5.6%0.3%5.1$10.71

Days to cover is short interest divided by FINRA's average daily volume for the period: how many average days of trading it would take shorts to buy back.

% of float uses the current float for every report (no float was stored with older reports).

Source: FINRA equity short interest (twice monthly) · Settlement Oct 15, 2026

Daily short volume

Share of each day's volume sold short · FINRA Reg SHO

Latest (Nov 11)
71.0%
3K of 4K
20-day average
45.8%
prior 39.2%
Percentile vs own history
97th
147 periods since 2025

Loading prices…

Short volumeRest of the day's volume

Source: FINRA Reg SHO daily short sale volume · Latest Nov 11, 2026

Short squeeze score (model)

Price since settlement: +0.3%

Model, not a forecast: 40 pts short interest % of float (full at 30%), 25 pts days to cover (full at 10), 15 pts rise in short interest since the prior report (full at +50%), 20 pts price gain since the settlement date (full at +25%). Missing inputs score 0.

DMAA's squeeze score and its inputs with Lician Pro.Start 3-day trial — $149/yr

Market-wide: most shorted stocks, biggest changes and unusual short volume · DMAA overview

Last 10 sessions · daily short volume · FINRA Reg SHO
DateShortTotalShort % of volume
2026-11-112,8934,07471.0%
2026-11-1010811197.3%
2026-11-0943212.5%
2026-11-0637642887.8%
2026-11-051166.3%
2026-11-0450069671.8%
2026-11-033933.3%
2026-11-021551.8%
2026-10-3011211894.9%
2026-10-293650.0%

Financials peers with similar quant ratings

DMAA among 524 rated Financials stocks (Lician quant rating, Nov 13, 2026). How the rating works

DMAA short interest FAQ

What is DMAA's short interest?

Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) had 89K shares sold short and not yet covered in FINRA's Oct 15, 2026 settlement report, 0.3% of its 27.3M-share float.

How many days to cover does DMAA have?

8.3 days: 89K shares short divided by an average daily volume of 11K for the Oct 15, 2026 period.

Is DMAA short interest rising or falling?

DMAA short interest was little changed (-0.8%) from 90K to 89K shares in the Oct 15, 2026 report.

Is DMAA a short squeeze candidate?

Lician's squeeze watch scores DMAA 21 out of 100 (low) from the Oct 15, 2026 report: short interest % of float 0.4/40, days to cover 20.8/25, change in short interest vs prior report 0/15, price change since settlement date 0.2/20. It is a transparent model of how crowded the short side is, not a forecast that a squeeze will happen.

What share of DMAA daily volume is sold short?

45.8% on average over the last 20 sessions to Nov 11, 2026 (FINRA Reg SHO daily short volume; the 97th percentile of its own 20-day averages). Short volume counts market makers' same-day short sales, so it is not short interest.

What was DMAA's latest FINRA short volume?

On Nov 11, 2026, cached FINRA short volume for Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) was 2,893 shares, 71.0% of 4,074 total volume.

How many DMAA short-volume sessions are listed on this page?

This page lists 10 cached FINRA short-volume sessions for Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA), from Oct 29, 2026 through Nov 11, 2026.

How did DMAA short volume percent change from the prior cached session?

Cached FINRA short volume for Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) moved from 97.3% on Nov 10, 2026 to 71.0% on Nov 11, 2026, down 26.3 percentage points.

Not investment advice. Figures as filed or reported, not a live feed.